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Allergol Immunopathol (Madr). 2009;37(5):272–278RESEARCH LETTERSAllergy to extensively hydrolysed formulasTo the Editor:
Cow’s milk allergy (CMA) is the most common childhood food
allergy,1 affecting 2–3% of the general population.2
After a correct diagnosis, complete avoidance of cow’s
milk proteins (CMP) is the only proven measure currently
available to prevent symptoms. CMA is frequently detected
in the ﬁrst year of life when nutritional requirements are
critical and adequate substitute is mandatory.
Formulas available for allergic children are extensive
hydrolysates of whey proteins, casein or mixed, amino acid
based formulas (AABF) and vegetable formulas such as soy,
rice or oat products.3 In Europe, extensively hydrolysed
formulas (EHF) are the ﬁrst-line substitution formulas for
CMA, especially recommended for infants under 6 months of
age with non-anaphylactic reactions.4,5 AABF are recom-
mended for children with EHF allergy and, according to
some authors, can be the best option for infants with
suspected multiple food allergy (MFA), previous anaphylaxis
or eosinophilic oesophagitis.5,6
Regarding allergenic potential, it is now evident that EHF
can induce adverse reactions in a substantial number of
infants with cow’s milk allergy. Extensively hydrolysed
formulas have 95% of peptides with less than 1500 Da and
only 0.5% superior to 6000 Da.3 Greater weights are less safe
as they have higher antigenic potential.3–5
Allergy to EHF has been reported as rare and some authors
suggest intolerance rates of approximately 10% among CMA
patients.6
We report six children, attended at Hospital Dona Estefa-
nia’s Immunoallergy Department, for IgE mediated CMA and
hypersensitivity to EHF, from the years 2005 to 2008 (Table 1).
Initial diagnosis was based on suggestive clinical manifesta-
tions, skin prick tests (SPT) and speciﬁc IgE determination for
milk and protein fractions (casein, alfa-lactoalbumin and beta-
lacto-globulin). Prick-prick tests with the implicated EHF
(PeptiJuniors) were performed in all patients Wheal reactions
equal or larger than 3mm were considered positive.
The reported cases are four boys and two girls, with ages
from 10 months to 6 years old (average age is 2.8 years).
First adverse reaction to CMP occurred in the ﬁrst 6
months of life for all patients and, in most cases (4:6)
immediately after ﬁrst ingestion of whole milk substitution
formula or other CMP form (ice cream or yogurt).
Immediate adverse reactions on contact with CMP
occurred in all patients and anaphylaxis was described in
four children, with mucocutaneous symptoms (urticariaand/or angio-oedema) present in all anaphylactic reactions.
Only one boy (12 months old) had chronic gastrointestinal
manifestations (vomiting) with growth retardation (weight:
percentile 10 at time of diagnosis).
Every patient had positive skin test results for milk, PF
and PeptiJuniors. Likewise, all patients had detectable
speciﬁc IgE for milk and PF.
One child, with previous anaphylaxis to CMP, was
positively tested for PeptiJuniors before its introduction
in diet and started accordingly on AABF. The other ﬁve
patients were initially prescribed EHF and adverse reactions
occurred after ﬁrst ingestion. Manifestations were identical
to previous CMA reactions except for one child with
preceding anaphylaxis, who experienced only eczema
exacerbation with EHF.
After EHF allergy was established, substitution formulas
were introduced. Soy formula was initiated in two
children, with 8 and 12 months old and negative SPT for
soy, who, for economic reasons, could not cope with
Neocates diet. Two other children changed to soy formula
after initiating AABF, for the same reason. All patients
showed tolerance to the prescribed formula, whether AABF
or soy product.
Three children have allergy to at least one more food
besides CMP (egg in two patients and four different foods in
the 6 year old girl). Three patients have persistent CMA over
the age of 3 and to date none has achieved tolerance. Two of
the three patients with persistent symptoms have allergy to
other foods.
Formulas approved for treatment of CMA, by deﬁnition,
should be tolerated by at least 90% of the infants with this
disorder.3 These criteria have been met by some extensive
hydrolysates and amino acid mixtures.
Traces of antigenically active molecules of CMP could
account for allergic reactions observed in individuals
sensitised to cow’s milk. This could be due to contamination
or incomplete enzymatic hydrolysis of native CMP. Polymers
and aggregates formed during the production and recon-
stitution of the formula can also be implicated. Further-
more, new allergenic epitopes may result from proteolysis
and heat treatment during manufacturing.
Several risk factors have been proposed for CMA devel-
opment but little is known concerning EHF allergy. Five of
our patients received whole milk formula at birth. Similarly,
other atopic symptoms are documented in 3:6 children
(two with eczema and one with asthma). These possible
correlations might offer interesting directions in future
studies.
Early and delayed manifestations have been associated
with EHF ingestion.
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Table 1 Allergy to extensively hydrolysed formulas: apropos of 6 patients
Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
1st Reaction (age) 6 months 4 months 4 months 5 months 5 months 6 months
CMP at birth + + – + + +
Exclusive breast
feeding
1 months 4 months 4 months 5 months 2 months 5 months
Atopic disease – Eczema Asthma – Eczema –
Manifestations
Respiratory Urticaria and
angio-oedema
Urticaria and
angio-oedema
Urticaria Urticaria and
angio-oedema
Eczema Urticaria
Gastrointestinal Vomits Vomits Abdominal
pain
Vomits
Mucocutaneous Wheezing Wheezing Wheezing
Other Anaphylaxis Anaphylaxis Anaphylaxis Anaphylaxis Growth delay,
anaemia
Other food allergy
(IgE mediated)
– Egg Egg – Egg, nuts, oat –
SPT
Milk + + + + + –
Casein + – + + + +
Alfa-albumin + – + + + +
Beta-globulin + – + + + +
EHF + (whey) + (whey) + (whey) + (whey and
casein)
+ (whey) + (whey)
Speciﬁc IgE (KU/L)
Milk 55.2 4100 4100 27.7 4100 29.7
Casein 54.8 30.5 4100 48.6 4100 44.4
Alfa-albumin 42.9 56.9 4100 51.5 4100 39.1
Beta-globulin 16.6 84.1 4100 22.6 42 29.3
Response to AABF Complete
resolution
Not tried Not tried Complete
resolution
Complete
resolution
Complete
resolution
Soy formula Not tried Good Good Good Good Not tried
Current age 3 years 2 years 4 years 10 months 6 years 12 months
Tolerance to CMP No No No No No No
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include acute adverse reactions, such as anaphylactic shock,
wheezing and urticaria.7 Most recently however, chronic
manifestations have been described, in particular vomiting,
diarrhoea, growth retardation and food rejection. The series
presented by Hill et al.,8 and Ammar et al.9 with 6 and 25
children respectively, show several common features. A
clear predominance of unspeciﬁc chronic manifestations
with gastrointestinal reactions in the ﬁrst place, followed by
irritability, eczema and growth retardation and reversibility
of symptoms with amino acid based formula are the most
relevant characteristics.
We report almost exclusively immediate adverse reactions,
suggesting type I hypersensitivity phenomena after EHF
ingestion (one patient also had concurrent eczema and late-
onset abdominal pain). Diagnosis is more easily assessed for
immediate symptoms than for delayed and unspeciﬁc mani-
festations. This may contribute to more frequent notiﬁcations
of IgE mediated reactions, as found in our hospital.
In our analysis, simultaneous allergy to other foods
besides CMP seems to have a worse prognosis. The
immunologic tolerance acquisition to EHF and CMP occurs
later, as has been suggested by other authors.8In the presence of allergy to other foods, a restricted diet
based on AABF is required for a longer duration. Isolated
CMA usually develops in the ﬁrst year of life and is
considered to be transitory in most cases (tolerance in 75%
of cases at age of 3 years).2 From our experience, all three
patients with other food allergies also had different atopic
symptoms (asthma or eczema) and two of them have
persistent CMA.
Concomitant reactions to different foods might be
explained by timing of diagnosis and introduction of solid
foods. This way, earlier diagnosis might prevent further
exposure to various food antigens, and thus, the develop-
ment of associated food allergies.
According to de Boissieu and Dupont, isolated EHF might
be a clinical condition both peculiar to the cow’s milk
allergenic residue, and limited to digestive manifestations.
In contrast, when participating in the more general process
of MFA, allergy to EHF could be more indicative of systemic
reactions.10
In conclusion, allergy to EHF seems to encompass two
different entities. A better prognosis is associated with an
earlier diagnosis, predominant digestive symptoms and
absence of MFA.
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allergy. However, most studies indicate substitution for an
amino acid-based formula. A different protein hydrolysate
form (whey vs. casein), is rarely effective in clinical practice
and more research on this subject is required.
Safety of AABF in children with CMA was ﬁrst reported by
Sampson et al. in 1992. Nevertheless, it is not clear for how
long should AABF diet be kept. Hill et al.8 reported the use
of AABF for more than 6 months in 6 infants with multiple
food allergy. In a long term follow-up evaluation of 52
children with CMA and allergy to EHF, AABF was used for
11.478 months (3.5 to 41 months) and tolerance to CMP was
achieved at a median age of 20.5 months.10
A recent European position statement has recommended
that soy-based formula should not be used as ﬁrst-line
treatment for infants with CMA under 6 months of age,
because few children had been studied and a high level of
concurrent soy allergy was detected. Nevertheless, this
substitute is nutritionally adequate, palatable and less
expensive than CMP based formulas.6
Information on soy formula utilisation in children with
allergy to EHF is scarce. Our experience demonstrates that
soy products can be helpful, particularly in families with low
ﬁnancial resources.
However, SPT for soy should be performed before dietary
introduction. High risk patients, as explained for CMA
patients, should be given special precaution.
Allergy to EHF is a rare condition under rising awareness.
A signiﬁcant number of case-reports have been noticed in
recent years.
Symptoms include immediate IgE mediated manifesta-
tions and/or chronic unspeciﬁc reactions, gastrointestinal in
the ﬁrst place. Although unspeciﬁc symptoms appear to be
more frequent, the authors found a clear predominance of
immediate reactions.
Early diagnosis is a good prognostic factor. When other
food intolerance is associated with EHF allergy, tolerance
acquisition appears to be more difﬁcult.
Management of these patients requires complete CMP
eviction and substitution for AABF. Soy formulas can also be
useful, especially in low income families, and prescription
should be established individually.References
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To the Editor:
Allergic disease is a common cause of morbidity, particularly
in young children, and its prevalence has increased in the last
20 years in most countries; and food allergy is the most
common cause of allergy in the ﬁrst years of life. Apparently
diet has an important inﬂuence in a lot of physiological
functions during pregnancy and childhood. Infants are exposed
to allergens which are being eaten by the mother and go
across placenta,1 and due to their intestinal immaturity canabsorb proteins with high molecular weight that have a lot of
allergenicity. This early exposure has an effect in humoral
response and can curb the development of tolerance.2
Food hypersensitivity is associated with the presence of
atopic dermatitis, gastrointestinal diseases and asthma.
Various authors have found a high prevalence of food
sensitisation in infants with atopic dermatitis3,4 and Abou-
diab et al. determined that cow’s milk proteins suppression
could improve the symptoms of children with asthma and
cow’s milk hypersensitivity.5
In a recent review by the Cochrane Group they concluded
that the use of hydrolysed formulas and other measures in
infants with a high risk of atopy could reduce the risk
of asthma in the ﬁrst year of life.6 Other studies have shown
